About Amgen (US: AMGN)
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics to healthcare providers worldwide, serving physicians and their clinics, dialysis centers, hospitals, and pharmacies through pharmaceutical wholesale distributors. The company's portfolio spans treatments for inflammatory conditions, bone disease, cardiovascular risk, oncology, and rare diseases, with principal products including Enbrel for rheumatoid arthritis and psoriatic conditions, Prolia and EVENITY for osteoporosis, Repatha for cardiovascular risk reduction, KYPROLIS for relapsed or refractory multiple myeloma, and BLINCYTO for acute lymphoblastic leukemia, among others.
Amgen's broader marketed portfolio extends to TEPEZZA for thyroid eye disease, KRYSTEXXA for chronic refractory gout, Otezla for plaque psoriasis and Behçet's disease, Vectibix for metastatic colorectal cancer, Aranesp for anemia, and Nplate for immune thrombocytopenia, alongside biosimilars and additional specialty medicines. The company maintains collaboration agreements with AstraZeneca, UCB, Kyowa Kirin, BeiGene, and BEONE Medicines to support the development and commercialization of select pipeline and marketed products. Incorporated in 1980, Amgen is headquartered in Thousand Oaks, California.
MFAM Research
- [BUY] Amgen (AMGN) – Biotech Giant With a Deep Pipeline and Growing PortfolioMarch 31, 2026Hold Amgen is a California biotechnology company that discovers, makes and sells medicines for cancer, heart disease, inflammation, bone health and kidney conditions. Institutional sell-side research rates it Buy because at least six growth areas, including obesity drug MariTide, Repatha, olpasiran and biosimilars, are launching or advancing together. Biosimilars have already earned US$13 billion in […]
A rules-based approach to leveraged ETFs
See how our quantitative strategy works and who it suits.
Explore the strategyBecome an authorised representative
Advise your clients under an established AFSL without building your own. Choose AR or CAR.
Become an AR or CARFinancial Summary
Price History
Related Stocks
| Same Industry — Healthcare | Same Sub-Industry — Drug Manufacturers - General |
|---|---|